{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L858R",
          "alt": "H117",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R H117"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The mutation in EGFR (evocational G-protein coupled receptor) is linked to Parkinson-like disease pathology.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links the mutation to Parkinson-like disease, indicating a mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The EGFR mutation is part of a broader class of mutations involved in neurodegenerative disorders.",
          "judgment": "Yes",
          "reasoning": "The assay is within the field of neurodegenerative disorder pathogenesis."
        },
        {
          "next_step_or_outcome": "Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The EGFR mutation is strongly associated with Parkinson-like disease pathogenesis, as it links to neurodegenerative processes."
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "R117",
          "alt": "H117",
          "position": "117"
        },
        "variant_string_id": "CFTR R117 H117"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The CFTR mutation is associated with Parkinson-like disease in a specific subset of patients.",
          "judgment": "Yes",
          "reasoning": "The mutation is described in the context of Parkinson-like disease, suggesting a benign association."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The CFTR mutation is part of a broader class of mutations in neurodegenerative disorders.",
          "judgment": "Yes",
          "reasoning": "The assay is within the field of neurodegenerative disorder pathogenesis."
        },
        {
          "next_step_or_outcome": "Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_moderate",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The CFTR mutation is moderately associated with Parkinson-like disease pathogenesis, as it links to neurodegenerative processes."
    }
  ],
  "overall_conclusion": "Both EGFR and CFTR mutations are strongly associated with Parkinson-like disease pathogenesis, with EGFR mutations showing a very strong association and CFTR mutations showing a moderate association."
}